Smoker Rates and Medical Cannabis: Oils vs Flower and What You'll Pay

Insurers are blunt instruments. They price risk from actuarial tables that were built long before medical cannabis existed as a category in the UK, so when a modern patient asks "am I a smoker?" the honest answer is: it depends what your insurer's application form actually asks and what you actually put in your lungs. This guide unpacks the format-matters rule, the numbers behind it, and how to answer the smoker question without either overpaying or invalidating your cover.

For the pillar overview see life insurance with a medical cannabis prescription, and for the mid-application version of the same problem see how to disclose a cannabis prescription on a life insurance application.

Why insurers ask the smoker question at all

Life insurance is priced on mortality. Smoking is one of the strongest single predictors an insurer has — a lifetime smoker's mortality curve is meaningfully steeper than a non-smoker's, and the industry has decades of claims data to prove it. That is why almost every UK proposal form asks about tobacco and nicotine use over the last 12 months, and increasingly about "any inhaled substances" or "vaping".

The clinical picture for prescribed medical cannabis flower is genuinely different from cigarette smoking — no combustion of tobacco, no tar in the same profile, medical-grade product, specialist oversight. But insurers price against their data, and they don't yet have long-run mortality data on inhaled CBPMs. In the absence of data, they default to the closest analogue in their manual — inhaled substances — and charge for it.

The format-matters rule

Almost every UK life insurer that will underwrite a medical cannabis patient at all sorts prescribed products into two buckets:

• Oral / non-inhaled formats — sublingual oils, tinctures, capsules, oromucosal sprays (Sativex), pastilles, edibles. These are treated as prescription medication only, with no smoker loading.
• Inhaled formats — dried flower via dry-herb vaporiser, vape cartridges, any smoked product. These almost always trigger smoker rates, regardless of the prescription.

A minority of specialist insurers now distinguish vaporised flower from smoked flower and charge a middle rate somewhere between standard and full smoker. That flexibility only appears through brokers who actively pre-underwrite with medical-cannabis-friendly insurers — the direct-to-consumer online journey almost never surfaces it.

What the premium actually looks like

The scale depends on age, sum assured, term length and every other health factor, but the pattern is consistent: smoker rates are usually 1.5x to 2.5x non-smoker rates on level term cover. Concretely, for illustration only:

• A healthy 35-year-old non-smoker on £300,000 / 25 years of level term might pay around £12–£16 per month.
• The same profile as a smoker often pays £24–£36 per month for the same cover.
• Over the 25-year term, that's £3,600 to £6,000 of extra premium — for the same benefit at the same claim event.

Numbers move constantly with market conditions; treat them as scale not quote. The point is that route of administration is one of the single largest levers on your premium — usually a bigger lever than sum assured, term length or occupation.

How to answer the smoker question honestly

The application asks two things in one field: do you smoke tobacco, and do you inhale anything else. UK insurance law (the Consumer Insurance (Disclosure and Representations) Act 2012) requires you to take reasonable care to answer accurately. In practice that means:

• If the question is "have you smoked tobacco in the last 12 months" and your prescribed flower contains no tobacco, the honest answer is no.
• If the question is "have you used any tobacco, nicotine or inhaled substances in the last 12 months" — the newer standard wording — a prescribed vaporised flower user must answer yes. The follow-up questions or the underwriter's letter is where you explain it is a prescribed CBPM.
• If the question is ambiguous, treat it as broad and disclose. It is not your job to interpret the question narrowly in your own favour — an underwriter reviewing a claim will read it broadly.

We cover the disclosure mechanics in depth in how to disclose a cannabis prescription on a life insurance application.

Switching from flower to oils to unlock non-smoker rates

If your clinical picture allows it, switching to non-inhaled formats is often the single most cost-effective insurance move a patient can make. Almost every UK insurer requires a continuous 12-month period of non-inhalation before you can be reclassified — a minority ask for 24. That's a policy decision for your clinician, not the insurer; some conditions genuinely need the fast onset that inhaled formats give, others don't.

If you're going to switch anyway, time it deliberately: apply for cover after the 12-month clock has run, not partway through. Applying at month 6 and asking the insurer to re-rate at month 12 rarely works — they price on the position at underwriting.

What if you're already covered on non-smoker rates and switch to flower?

Your existing policy usually stays priced as it was written — insurers cannot retrospectively re-rate an in-force term life policy because your habits changed. What they can do is treat non-disclosure of a material change as grounds to void cover at claim if the change happened before the application. If the change happens after the policy is in force, you generally do not need to notify. The wording of your policy is decisive; check it, and if in doubt call the insurer's underwriting line (not the customer service line) and get the answer in writing.

This is exactly the trap covered in I started a prescription after taking out life insurance — do I need to tell them? — same logic, applied to the underlying prescription rather than the format.

The bottom line

Route of administration is the underwriting fact, not the prescription. Oils, capsules and sprays keep you on non-smoker rates almost everywhere. Flower and vape cartridges usually don't. If you have a choice clinically and cost matters, oils are almost always the right insurance answer. If you don't have a choice, a broker who knows the medical-cannabis-friendly panel is worth the introduction — the price gap between the best and worst quotes for the same patient can be 3x.